25 million Americans
live with tinnitus.
Sontriva is ready.
Sontriva US, Inc. is bringing Europe's patent-protected digital tinnitus program to the American market. Request access to receive the investor overview for our current round.
Patent protected until 2036
Sontriva's core technology is protected by patent through 2036 — a durable moat in the fast-growing digital hearing-health category.
A clear pathway into the US
A well-trodden regulatory route into the US market: Sontriva US is pursuing FDA 510(k) clearance with an experienced regulatory team behind it.
Proven in Europe
Engineered under Europe's strict medical-device regulation and built on the team's existing European track record — the foundation for US expansion.
A vast market, still waiting for a scalable answer.
Reserve your allocation
Request access in under two minutes. You'll receive the investor overview and updates on the current round — no commitment.
Frequently asked questions
The Sontriva app, in your pocket.
Personalized sound therapy, session tracking, and daily progress — this is the product Sontriva US is bringing to the American market.
